The home of the Audio Journal of Oncology

Late-Stent Throbosis Risk after Clopidogrel Withdrawal: Greater in Drug Eluting Stents

AudioMedica News
AudioMedica News
Late-Stent Throbosis Risk after Clopidogrel Withdrawal: Greater in Drug Eluting Stents
Late-Stent Throbosis Risk after Clopidogrel Withdrawal: Greater in Drug Eluting Stents
/
Matthias Pfisterer
Matthias Pfisterer, University Hospital Basel
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 422-11. Lancet 2005:366:921
Clopidogrel therapy may need to be prolonged among patients treated with angioplasty plus drug eluting stent implantation as compared with those getting bare metal stents. That’s the outcome of the BASKET (Basel Stent Cost Effectiveness Trials) study announced at the American College of Cardiology conference in Atlanta. Sarah Maxwell heard results from Matthias Pfisterer from Basel.
[audio:https://www.audiomedica.com/podcasting/acc2006/matthias_pfisterer.mp3]

Further reading

Sign up for AudioMedica.com news

* = required field
Speciality